Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Innoviva (INVA) Invested Capital (2016 - 2026)

Innoviva filings provide 17 years of Invested Capital readings, the most recent being $1.2 billion for Q4 2025.

  • On a quarterly basis, Invested Capital rose 23.79% to $1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 billion, a 23.79% increase, with the full-year FY2025 number at $1.2 billion, up 23.79% from a year prior.
  • Invested Capital hit $1.2 billion in Q4 2025 for Innoviva, up from $1.0 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $1.2 billion in Q4 2025 to a low of $491.8 million in Q3 2021.
  • Median Invested Capital over the past 5 years was $720.6 million (2022), compared with a mean of $773.2 million.
  • Biggest five-year swings in Invested Capital: soared 71.65% in 2021 and later plummeted 31.0% in 2022.
  • Innoviva's Invested Capital stood at $959.4 million in 2021, then plummeted by 31.0% to $662.0 million in 2022, then surged by 40.47% to $929.9 million in 2023, then grew by 1.89% to $947.5 million in 2024, then grew by 23.79% to $1.2 billion in 2025.
  • The last three reported values for Invested Capital were $1.2 billion (Q4 2025), $1.0 billion (Q3 2025), and $906.7 million (Q2 2025) per Business Quant data.